A new study suggests that caregivers need and want to access support resources and that perhaps the experience of caregiving has made them consider the possibility of their own future needs. And there is no doubt that the current number and expected increase in the foreseeable future of individuals with dementia and Alzheimer's disease will necessitate it.
According to the Alzheimer's Association, "the number of Americans living with Alzheimer's disease is growing — and growing fast. An estimated 5.5 million Americans of all ages have Alzheimer's disease."
Of those Americans living with Alzheimer's dementia in 2017:
One in 10 people age 65 and older (10 percent) has Alzheimer's dementia. Almost two-thirds of Americans with Alzheimer's are women. African-Americans are about twice as likely to have Alzheimer's or other dementias as older whites. Hispanics are about one and one-half times as likely to have Alzheimer's or other dementias as older whites."Because of the increasing number of people age 65 and older in the United States, particularly the oldest-old, the number of new cases of Alzheimer's and other dementias is projected to soar," the Alzheimer's Association states at alz.org. "Today, someone in the United States develops Alzheimer's dementia every 66 seconds. By mid-century, someone in the United States will develop the disease every 33 seconds."
Top Heal Care Stocks To Buy Right Now: LivaNova PLC(LIVN)
Advisors' Opinion:- [By Shane Hupp]
LivaNova (NASDAQ:LIVN) and Masimo (NASDAQ:MASI) are both mid-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, analyst recommendations, valuation, risk and profitability.
- [By Joseph Griffin]
Shares of LivaNova PLC (NASDAQ:LIVN) have received a consensus rating of “Buy” from the eleven research firms that are covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, three have given a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $88.57.
- [By Shane Hupp]
Stifel Nicolaus started coverage on shares of LivaNova (NASDAQ:LIVN) in a research report released on Friday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $115.00 target price on the stock.
- [By Max Byerly]
LivaNova PLC (NASDAQ:LIVN) has received an average rating of “Buy” from the nine brokerages that are currently covering the company, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation, five have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $118.20.
- [By Max Byerly]
Get a free copy of the Zacks research report on LivaNova (LIVN)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top Heal Care Stocks To Buy Right Now: Huaneng Power International, Inc.(HNP)
Advisors' Opinion:- [By Stephan Byrd]
Huaneng Power International (NYSE: HNP) and Avangrid (NYSE:AGR) are both large-cap utilities companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, valuation, profitability and institutional ownership.
- [By Ethan Ryder]
Huaneng Power International Inc (NYSE:HNP) has been assigned an average recommendation of “Hold” from the six analysts that are covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and two have issued a buy recommendation on the company.
- [By Max Byerly]
CEMIG (NYSE:CIG) and Huaneng Power International (NYSE:HNP) are both mid-cap utilities companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, risk and profitability.
- [By Ethan Ryder]
Media coverage about Huaneng Power International (NYSE:HNP) has been trending somewhat positive on Sunday, Accern Sentiment reports. Accern identifies negative and positive press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Huaneng Power International earned a news impact score of 0.04 on Accern’s scale. Accern also gave news articles about the utilities provider an impact score of 46.9751001433333 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
Top Heal Care Stocks To Buy Right Now: Capital Southwest Corporation(CSWC)
Advisors' Opinion:- [By Stephan Byrd]
Press coverage about Capital Southwest (NASDAQ:CSWC) has been trending positive recently, Accern Sentiment Analysis reports. Accern ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Capital Southwest earned a coverage optimism score of 0.27 on Accern’s scale. Accern also assigned news stories about the asset manager an impact score of 44.9331419606621 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
- [By Joseph Griffin]
Capital Southwest Co. (NASDAQ:CSWC) announced a quarterly dividend on Tuesday, June 5th, Wall Street Journal reports. Investors of record on Tuesday, June 26th will be paid a dividend of 0.29 per share by the asset manager on Monday, July 2nd. This represents a $1.16 annualized dividend and a dividend yield of 6.80%. The ex-dividend date of this dividend is Monday, June 25th. This is a boost from Capital Southwest’s previous quarterly dividend of $0.28.
- [By Logan Wallace]
Advisors Asset Management Inc. decreased its stake in shares of Capital Southwest Co. (NASDAQ:CSWC) by 5.6% in the 2nd quarter, Holdings Channel reports. The firm owned 82,556 shares of the asset manager’s stock after selling 4,935 shares during the quarter. Advisors Asset Management Inc.’s holdings in Capital Southwest were worth $2,164,000 at the end of the most recent quarter.
- [By Max Byerly]
Capital Southwest (NASDAQ: CSWC) and TRIPLEPOINT VEN/COM (NYSE:TPVG) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations.
- [By Motley Fool Staff]
Capital Southwest (NASDAQ:CSWC) Q4 2018 Earnings Conference CallJun. 5, 2018 11:00 a.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
Top Heal Care Stocks To Buy Right Now: TransAct Technologies Incorporated(TACT)
Advisors' Opinion:- [By Ethan Ryder]
TransAct Technologies Incorporated (NASDAQ:TACT) Chairman Bart C. Shuldman sold 1,272 shares of TransAct Technologies stock in a transaction dated Tuesday, September 4th. The stock was sold at an average price of $14.35, for a total value of $18,253.20. Following the completion of the transaction, the chairman now directly owns 18,205 shares in the company, valued at approximately $261,241.75. The sale was disclosed in a document filed with the SEC, which is available at this link.
- [By Logan Wallace]
Get a free copy of the Zacks research report on TransAct Technologies (TACT)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Ethan Ryder]
Logitech (NASDAQ: LOGI) and TransAct Technologies (NASDAQ:TACT) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, analyst recommendations, risk, earnings and profitability.
- [By Stephan Byrd]
Get a free copy of the Zacks research report on TransAct Technologies (TACT)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
No comments :
Post a Comment